| #390 |
Daniel MAZUR |
Thermo Fisher |
4 |
| #390 |
Koohyar Minoo |
Arris Enterprises |
4 |
| #390 |
Kavya B. Ravikumar |
Apple |
4 |
| #390 |
Amit Shah |
IBM |
4 |
| #390 |
Rafie Shamsaasef |
Arris Enterprises |
4 |
| #390 |
Linda Stacey Irish |
Qualcomm |
4 |
| #390 |
Timo Ville VINTOLA |
Qualcomm |
4 |
| #390 |
Daiting Rong |
Dexcom |
4 |
| #390 |
Jacob S. Leach |
Dexcom |
4 |
| #390 |
Wei YANG |
Orbbec |
4 |
| #390 |
Megha Cila |
Singular Genomics Systems |
4 |
| #390 |
Bryan Becklund |
Inhibrx |
4 |
| #390 |
Heesun Shin |
LG |
4 |
| #390 |
Keming Cao |
Qualcomm |
4 |
| #390 |
Michiel Petrus Lotter |
Apple |
4 |
| #390 |
Chenzhe Qian |
Tusimple |
4 |
| #390 |
Venu Gutlapalli |
Ferret Systems |
4 |
| #390 |
Christian Reber Wester |
Taylor Made Golf Company |
4 |
| #390 |
Hsiao-Chiang Chuang |
Qualcomm |
4 |
| #390 |
William H. Huisman |
Sirigen Ii Limited |
4 |
| #390 |
Ian Muceus |
Battle Born Supply |
4 |
| #390 |
Thomas B. Buford |
Nuvasive Specialized Orthopedics |
4 |
| #390 |
Jun Feng |
Araxes Pharma |
4 |
| #390 |
Ashish Kumar |
Illumina |
4 |
| #390 |
Sinan ARSLAN |
Element Biosciences |
4 |
| #390 |
Sivaram Srivenkata PALAKODETY |
Qualcomm |
4 |
| #390 |
Aniket PATIL |
Qualcomm |
4 |
| #390 |
Andrew KENNEDY |
Agilent Technologies |
4 |
| #390 |
David Schmidt |
Brunswick |
4 |
| #390 |
Ted Ray Gooding |
Qualcomm |
4 |
| #390 |
Yi Liu |
Federal Home Loan Mortgage Corporation (“Freddie Mac”) |
4 |
| #390 |
Michael V. Williams |
Xr Downhole |
4 |
| #390 |
Li Liu |
Qualcomm |
4 |
| #390 |
Vinod V. Panikkath |
Qualcomm |
4 |
| #390 |
Richard Dominic Wietfeldt |
Qualcomm |
4 |
| #390 |
Edward T. Maggio |
Aegis Therapeutics |
4 |
| #390 |
Sheshi Nyalamadugu |
Ballogy |
4 |
| #390 |
Yue Li |
Lemon |
4 |
| #390 |
Ahmad Bassil Zoubi |
Qualcomm |
4 |
| #390 |
Arnold Jason Gum |
Qualcomm |
4 |
| #390 |
Aaron Craig Burns |
Mirati Therapeutics |
4 |
| #390 |
Marc Ische |
Qualcomm |
4 |
| #390 |
Le Nguyen Luong |
Qualcomm |
4 |
| #390 |
Pankaj Deshmukh |
Qualcomm |
4 |
| #390 |
Lizabeth Keser |
Intel |
4 |
| #390 |
Daniel Amerga |
Qualcomm |
4 |
| #390 |
Cheng-Yi Chen |
Merck |
4 |
| #390 |
James Gail Christensen |
Mirati Therapeutics |
4 |
| #390 |
James Paul Lajiness |
Novartis Ag |
4 |
| #390 |
Xiuwen Zhu |
Arena Pharmaceuticals |
4 |